Carbidopa in Parkinson disease and in nausea and vomiting of levodopa.
D000368:Aged; D001264:Athetosis / Q000139:chemically induced; D002230:Carbidopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002819:Chorea / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced* / Q000517:prevention & control; D010300:Parkinson Disease / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control
D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002230:Carbidopa